Ginsenoside Rg1 protects against transient focal cerebral ischemic injury and suppresses its systemic metabolic changes in cerabral injury rats

Acta Pharmaceutica Sinica B

Volumn 5, Issue 3, 2015, Pages 277-284

  Lin, Mingbao ^a   Sun, Wei ^b   Gong, Wan ^c   Ding, Yasi ^a   Zhuang, Yuanyan ^a   Hou, Qi ^a  

^a INSTITUTE OF MATERIA MEDICA   (China)

^b CAPITAL MEDICAL UNIVERSITY   (China)

^c ZHEJIANG CHINESE MEDICAL UNIVERSITY   (China)

Author keywords

Biomarkers; Ginsenoside Rg1; MCAO; Metabolites

Indexed keywords

GINSENOSIDE RG 1;

ANIMAL EXPERIMENT; ARTICLE; BRAIN INFARCTION SIZE; BRAIN INJURY; BRAIN ISCHEMIA; CHINESE MEDICINE; CONTROLLED STUDY; DRUG MECHANISM; DRUG STRUCTURE; FEEDBACK SYSTEM; GAS CHROMATOGRAPHY; GINSENG; IN VIVO STUDY; MALE; MASS SPECTROMETRY; MIDDLE CEREBRAL ARTERY OCCLUSION; NEUROPROTECTION; NONHUMAN; PANAX NOTOGINSENG; RAT; REGULATORY MECHANISM; SCORING SYSTEM; TRANSIENT ISCHEMIC ATTACK;

EID: 84947202361     PISSN: 22113835     EISSN: 22113843     Source Type: Journal    
DOI: 10.1016/j.apsb.2015.02.001     Document Type: Article

References (23)

1. Cheng Y.D., Al-Khoury L., Zivin J.A. Neuroprotection for ischemic stroke: two decades of success and failure. NeuroRx 2004, 1:36-45.
2. Curry S.H. Why have so many drugs with stellar results in laboratory stroke models failed in clinical trials? A theory based on allometric relationships. Ann NY Acad Sci 2003, 993:69-74.
3. Gladstone D.J., Black S.E., Hakim A.M. Toward wisdom from failure: lessons from neuroprotective stroke trials and new therapeutic directions. Stroke: J Cereb Circ 2002, 33:2123-2136.
4. Kiefer D., Pantuso T. Panax ginseng. Am Fam Physician 2003, 68:1539-1542.
5. Kehong Y., Shuxing G., Bingying X., Junling Y., Lanou W. Variation of BDNF mRNA on focol cerebral ischemia reperfusion injury in rats with notogisenoside Rg1. J Chin Med Mater 2007, 30:313-316.
6. Chen X.C., Zhou Y.C., Chen Y., Zhu Y.G., Fang F., Chen L.M. Ginsenoside Rg1 reduces MPTP-induced substantia nigra neuron loss by suppressing oxidative stress. Acta Pharmacol Sin 2005, 26:56-62.
7. Ge K.L., Chen W.F., Xie J.X., Wong M.S. Ginsenoside Rg1 protects against 6-OHDA-induced toxicity in MES23.5 cells via AKT and ERK signaling pathways. J Ethnopharmacol 2010, 127:118-123.
8. Wang R., Li Y.N., Wang G.J., Hao H.P., Wu X.L., Zhou F. Neuroprotective effects and brain transport of ginsenoside Rg1. Chin J Nat Med 2009, 7:315-320.
9. Yao H., Shi P., Zhang L., Fan X., Shao Q., Cheng Y. Untargeted metabolic profiling reveals potential biomarkers in myocardial infarction and its application. Mol Biosyst 2010, 6:1061-1070.
10. Chen M., Ni Y., Duan H., Qiu Y., Guo C., Jiao Y., et al. Mass spectrometry-based metabolic profiling of rat urine associated with general toxicity induced by the multiglycoside of tripterygium wilfordii hook. F. Chem Res Toxicol 2008, 21:288-294.
11. Chen M., Zhao L., Jia W. Metabonomic study on the biochemical profiles of a hydrocortisone-induced animal model. J Proteome Res 2005, 4:2391-2396.
12. Yang J., Xu G., Hong Q., Liebich H.M., Lutz K., Schmulling R.M., et al. Discrimination of type 2 diabetic patients from healthy controls by using metabonomics method based on their serum fatty acid profiles. J Chromatogr B Anal Technol Biomed Life Sci 2004, 813:53-58.
13. Jiang Z., Sun J., Liang Q., Cai Y., Li S., Huang Y., et al. A metabonomic approach applied to predict patients with cerebral infarction. Talanta 2011, 84:298-304.
14. Wang Q., Peng Y., Chen S., Gou X., Hu B., Du J., et al. Pretreatment with electroacupuncture induces rapid tolerance to focal cerebral ischemia through regulation of endocannabinoid system. Stroke: J Cereb Circ 2009, 40:2157-2164.
15. Sasaki M., Honmou O., Kocsis J.D. A rat middle cerebral artery occlusion model and intravenous cellular delivery. Methods Mol Biol 2009, 549:187-195.
16. Longa E.Z., Weinstein P.R., Carlson S., Cummins R. Reversible middle cerebral artery occlusion without craniectomy in rats. Stroke: J Cereb Circ 1989, 20:84-91.
17. Dalal P., Bhattacharjee M., Vairale J., Bhat P. International stroke society-who global stroke initiative: a report on population-based mumbai stroke registry (2005-2006), India. Int J Stroke 2009, 4:239-240.
18. Bonita R., Mendis S., Truelsen T., Bogousslavsky J., Toole J., Yatsu F. The global stroke initiative. Lancet Neurol 2004, 3:391-393.
19. Zheng G.Q., Cheng W., Wang Y., Wang X.M., Zhao S.Z., Zhou Y., et al. Ginseng total saponins enhance neurogenesis after focal cerebral ischemia. J Ethnopharmacol 2010, 133:724-728.
20. He L., Chen X., Zhou M., Zhang D., Yang J., Yang M., et al. Radix/rhizoma notoginseng extract (sanchitongtshu) for ischemic stroke: a randomized controlled study. Phytomedicine 2010, 18:437-442.
21. Liu Q., Kou J.P., Yu B.Y. Ginsenoside Rg1 protects against hydrogen peroxide-induced cell death in PC12 cells via inhibiting NF-κB activation. Neurochem Int 2011, 58:119-125.
22. 2+ channels. Eur J Pharmacol 2008, 586:90-99.
23. Berthet C., Lei H., Gruetter R., Hirt L. Early predictive biomarkers for lesion after transient cerebral ischemia. Stroke: J Cereb Circ 2011, 42:799-805.